Your session is about to expire
← Back to Search
Surgery + Photodynamic Therapy for Mesothelioma (MPM-PDT Trial)
MPM-PDT Trial Summary
This trial is testing whether adding a light-based therapy to surgery and chemo can improve survival in people with a certain type of lung cancer.
MPM-PDT Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowMPM-PDT Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.MPM-PDT Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I can carry out all my daily activities without help.I do not have severe liver disease or very high liver test results.I received my last dose of pemetrexed less than 30 days before my planned surgery.I have no active cancer needing treatment, except for certain skin, bladder, cervical, or early prostate cancers.It has been over 30 days since my last pemetrexed treatment.I am medically cleared for surgery, including heart health.I understand the risks and benefits of this study and can sign the consent form.I have a history of HIV.I have received Mantle field radiation before.I have received more than 2 rounds of chemotherapy before surgery.I have a specific type of mesothelioma and can potentially have all visible tumor removed.It's been over 30 days since my last cancer treatment.My cancer has spread beyond one side of my chest.My cancer is confined to one side of my chest.Your blood count shows a low number of white blood cells or platelets.Your blood creatinine level is 2.5 mg/dL or higher.I am 18 years old or older.
- Group 1: patients who undergo RP alone
- Group 2: patients who undergo RP plus photofrin-based PDT
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has the FDA officially validated Radical Pleurectomy as a treatment option?
"We appraised the safety of radical pleurectomy to be 2, owing to its Phase 2 status with limited data attesting to efficacy but some evidence of security."
How many participants is this trial limited to?
"Affirmative. Evidence on clinicaltrials.gov reveals that this investigation is actively enrolling patients, with the first posting occuring on May 1st 2014 and a recent update being made July 25th 2022. 102 participants are desired between two distinct medical centres."
Is it feasible for individuals to join this trial at present?
"Affirmative. Clinicaltrials.gov provides evidence that this medical experiment, first posted on May 1st 2014, is in need of participants to move forward with the trial. The study intends to recruit 102 individuals from 2 different locations."
What former investigations have been conducted on Radical Pleurectomy?
"Currently, the landscape of Radical Pleurectomy clinical trials are in Phase 1 and 2. There is a concentration of studies running out of Philadelphia, Pennsylvania but 6 medical sites across the United States have active investigations into this procedure."
Share this study with friends
Copy Link
Messenger